Status: Not yet recruiting
Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva.
Participants needed: 10
Trial details
Age: 18-120Biological sex: FemaleType: InterventionalSponsor: Alpha Tau Medical LTD.Updated: Jan 31, 2024
Eligibility criteria
Histologically confirmed newly diagnosed or recurrent (local) vulva SCC with or... [+16]
Concomitant chemotherapy or immunotherapy within the past 4 weeks [+12]